Understanding iron deficiency (ID)
ID is one of the most common nutritional disorders in the world2.
The terms anaemia, ID and iron deficiency anaemia (IDA) are sometimes used interchangeably, however ID can occur with or without the presence of anaemia2
IDA occurs in 2-5% of adult men and post-menopausal women in the developed world3
In the UK the prevalence of IDA in adults is highest in females aged 35-49 years, free-living adults aged ≥ 85 years and institutionalised men aged ≥ 65 years4
Mode of Action Video
FERACCRU® contains the ferric form of iron (Fe3+)1. Most oral iron treatments contain the ferrous form of iron (Fe2+).3,5-7
FERACCRU® creates a stable complex by tightly binding ferric iron to three maltol molecules.1
Unlike oral ferrous salts (Fe2+) salts, the Fe3+ in FERACCRU® remains tightly bound to maltol until the point of iron absorption.1,8,9
It’s this unique structure that makes it an efficacious and well-tolerated (vs placebo) oral iron treatment for adult patients with ID, demonstrated in Phase 3 studies in Inflammatory Bowel Disease (IBD).10,11